A Brassica napus transcript encoding a protein related to the Kunitz protease inhibitor family accumulates upon water stress in leaves, not in seeds.

Radiolabeled annexin V (ANV) has been widely used for imaging cell apoptosis. Recently, a novel ANV-Kunitz-type protease inhibitor fusion protein, ANV-6L15, was found to be a promising probe for improved apoptosis detection based on its higher affinity to phosphatidylserine (PS) compared to native ANV. The present paper investigates the feasibility of apoptosis detection using radioiodinated ANV-6L15. Native ANV and ANV-6L15 were labeled with iodine-123 and iodine-125 using Iodogen method. The binding between the radioiodinated proteins and erythrocyte ghosts or chemical-induced apoptotic cells was examined. ANV-6L15 can be radioiodinated with high yield (40%−60%) and excellent radiochemical purity (>95%).123I-ANV-6L15 exhibited a higher binding ratio to erythrocyte ghosts and apoptotic cells compared to123I-ANV. The biodistribution of123I-ANV-6L15 in mice was also characterized.123I-ANV-6L15 was rapidly cleared from the blood. High uptake in the liver and the kidneys may limit the evaluation of apoptosis in abdominal regions. Our data suggest that radiolabled ANV-6L15 may be a better scintigraphic tracer than native ANV for apoptosis detection.

Download Full-text

Induction of secondary dormancy in rape seeds (Brassica napus L.) by prolonged imbibition under conditions of water stress or oxygen deficiency in darkness

European Journal of Agronomy ◽

10.1016/s1161-0301(96)02051-5 ◽

1997 ◽

Vol 6 (3-4) ◽

pp. 245-255 ◽

Cited By ~ 63

Author(s):

C. Pekrun ◽

P.J.W. Lutman ◽

K. Baeumer

Keyword(s):

Water Stress ◽

Brassica Napus ◽

Oxygen Deficiency ◽

Brassica Napus L ◽

Secondary Dormancy

Download Full-text

Kunitz Protease Inhibitor-Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease

Journal of Neuropathology & Experimental Neurology ◽

10.1097/00005072-199201000-00009 ◽

1992 ◽

Vol 51 (1) ◽

pp. 76-83 ◽

Cited By ~ 96

Author(s):

B. T. Hyman ◽

R. E. Tanzi ◽

K. Marzloff ◽

R. Barbour ◽

D. Schenk

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Protease Inhibitor ◽

Amyloid Β ◽

Amyloid Β Protein ◽

Protein Precursor ◽

Β Protein ◽

Kunitz Protease Inhibitor

Download Full-text

A genetically engineered human Kunitz protease inhibitor with increased kallikrein inhibition in an ovine model of cardiopulmonary bypass

Perfusion ◽

10.1177/026765910101600305 ◽

2001 ◽

Vol 16 (3) ◽

pp. 199-206 ◽

Cited By ~ 3

Author(s):

Sunil K Ohri ◽

Rachel Parratt ◽

Tyler White ◽

Jenny Becket ◽

John J Brannan ◽

...

Keyword(s):

Cardiopulmonary Bypass ◽

Protease Inhibitor ◽

Randomized Study ◽

Genetically Engineered ◽

Wild Type ◽

Ovine Model ◽

Double Blind ◽

Perioperative Bleeding ◽

Kunitz Inhibitor ◽

Kunitz Protease Inhibitor

A recombinant human serine protease inhibitor known as Kunitz protease inhibitor (KPI) wild type has functional similarities to the bovine Kunitz inhibitor, aprotinin, and had shown a potential to reduce bleeding in an ovine model of cardiopulmonary bypass (CPB). The aim of this study was to assess KPI-185, a modification of KPI-wild type that differs from KPI-wild type in two amino acid residues and which enhances anti-kallikrein activity in a further double-blind, randomized study in an ovine model of CPB, and to compare with our previous study of KPI-wild type and aprotinin in the same ovine model. Post-operative drain losses and subjective assessment of wound ‘dryness’ showed no significant differences between KPI-185 and KPI-wild type, despite the significant enhancement of kallikrein inhibition using KPI-185 seen in serial kallikrein inhibition assays. These preliminary findings support the hypothesis that kallikrein inhibition is not the major mechanism by which Kunitz inhibitors such as aprotinin reduce perioperative bleeding.

Download Full-text